Abstract

Genetic disorders screening has become a crucial component of modern healthcare, enabling early detection and management of inherited conditions. This article explores the various approaches to genetic screening, including newborn screening, carrier screening, and prenatal testing. It highlights advancements in screening technologies, such as next-generation sequencing and expanded panel testing, and discusses their impact on patient outcomes and public health. The article also addresses challenges related to ethical considerations, cost, and accessibility. Finally, it outlines future directions for genetic disorders screening, emphasizing the need for continuous innovation and equitable implementation